InsidersTradesSigma
Track the 한스바이오메드 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 한스바이오메드 has recorded 6 public disclosures. Market capitalisation: €288.8bn. The latest transaction was reported on 9 June 2026 (Sale). Among the most active insiders: 네오영. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hans Biomed 是一家专注于医疗保健和制药领域的公司，在XKRX市场上市。它致力于开发创新的生物医学解决方案。